Difference between revisions of "Team:NCTU Formosa/Overview"
| Line 8: | Line 8: | ||
<script src="https://2015.igem.org/Team:NCTU_Formosa/mordernizr.js?action=raw&ctype=text/javascript"></script> <!-- Modernizr --> | <script src="https://2015.igem.org/Team:NCTU_Formosa/mordernizr.js?action=raw&ctype=text/javascript"></script> <!-- Modernizr --> | ||
| − | <style | + | <style type=text/css> |
body { | body { | ||
| Line 160: | Line 160: | ||
position: relative; | position: relative; | ||
height: 300px; | height: 300px; | ||
| − | margin-top: | + | margin-top: 20px; |
| − | z-index: | + | z-index: 1; |
} | } | ||
#cd-intro #cd-intro-background { | #cd-intro #cd-intro-background { | ||
Revision as of 12:55, 4 September 2015
APOllO E.Cotector
With our hit product, we provide the convenient and efficient diagnosis for prescribing personalized targeted drug therapy via tissue biopsies. To achieve this promising goal, the APOllO E.Cotector not only displays single chain variable fragment (scFv) which are directly from monoclonal antibody targeted drugs as probes to detect specific biomarkers, but also simultaneously expresses the florescent protein as signal for instant observation. Furthermore, by changing various kinds of scFv on the surfaces of E.Cotectors, it can identify multimarker and suggest